US Edition
News from Stockhead
We’ve assigned a rating of Unknown factuality to Stockhead. You can read more about how we’ve determined Stockhead’s credibility and reliability as a news source here: https://ground.news/rating-system.
Media Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Stockhead News
Australia · AustraliaRecruitment complete in Dimerix’s ACTION3 phase III clinical trial of DMX-200 in rare kidney disease focal segmental glomerulosclerosis The global trial has recruited and dosed its target 286th adult patient with 69 patients already completing the full two-year treatment period Dimerix and US partner Amicus Therapeutics to seek FDA feedback on trial endpoints following PARASOL findings Special Report: Dimerix has achieved a key catalyst before…See the Story
Pre-Christmas milestone for Dimerix as ACTION3 phase III fully recruited
Utah · UtahHost Tylah Tully unpacks news that Trigg Minerals has officially changed its name to American Tungsten & Antimony (ASX:AT4) to better reflect the company’s growing focus on US critical minerals. AT4 continues to progress its flagship Antimony Canyon project in Utah and the Tennessee Mountain tungsten project in Nevada, with the strategic goal of becoming a leading, diversified critical minerals and defence metals company. Watch the video for mor…See the Story
